Tianjin Medical University Second Hospital

This study is testing whether a urine test that detects cancer DNA can help doctors decide how long to continue immunotherapy in patients with a high-risk form of bladder cancer that cannot be fully removed by surgery. Participants will receive immunotherapy, and if their cancer …

This study is testing whether a combination of two drugs—an antibody-drug conjugate and an immunotherapy drug—can help control aggressive forms of prostate cancer that have stopped responding to standard hormone therapies. It will enroll 28 men in China with advanced, fast-growin…

This study is for people with high-risk cancer in their kidney or ureter (the tube to the bladder). It compares two types of surgery: the standard operation versus the standard operation plus a more thorough removal of nearby lymph nodes. Researchers want to see if the more exten…

This study is testing whether a combination of two drugs, tislelizumab and nab-paclitaxel, can effectively treat a type of kidney cancer located in the renal pelvis. The main goal is to control the cancer for at least one year while avoiding the need to surgically remove the enti…

This study is testing a three-part treatment given before surgery for advanced kidney cancer. The goal is to shrink the tumor and make it easier to remove completely. The treatment involves a procedure to block the tumor's blood supply, followed by immunotherapy and targeted drug…

This study is testing if a non-invasive urine test can help doctors decide which patients with early-stage bladder cancer need a second surgery. Currently, many patients get a second surgery to check for leftover cancer, but it might not be needed for everyone. The goal is to use…

This study is testing whether giving two newer cancer drugs together before surgery can help people with a specific type of high-risk upper tract bladder cancer. The drugs, tislelizumab and disitamab vedotin, aim to shrink the tumor and improve surgical outcomes, especially for p…

This study is testing an experimental drug called tunlametinib for people with advanced solid cancers that have stopped responding to other treatments and have a specific genetic change called an NRAS mutation. The main goal is to see if the drug can shrink tumors and control the…

This study is testing whether a non-invasive urine test that looks for cancer DNA can help doctors decide when patients with high-risk bladder cancer need a follow-up cystoscopy. Cystoscopy is an effective but uncomfortable camera exam of the bladder. Researchers want to see if u…

This study is testing whether a non-invasive urine test can help doctors decide which patients with high-risk bladder cancer truly need a second surgery. Currently, many patients get this second procedure as a precaution, but it carries risks and costs. Researchers will compare t…

This study is testing a new type of test, called a liquid biopsy, that uses blood and urine samples to help with bladder cancer. The goal is to see if this test can help doctors diagnose the cancer, see how well treatment is working, and spot if the cancer comes back. Researchers…